Partnership & Collaborations Archives | Page 42 of 83 | Be Korea-savvy

Archive by category Partnership & Collaborations

Mastercard and FreedomPay Unlock Global Commerce With New Payment Gateway Partnership

Mastercard and FreedomPay Unlock Global Commerce With New Payment Gateway Partnership

Collaboration Expands Reach to 230+ Acquirers, Streamlining International Transactions for Businesses PHILADELPHIA, Jan. 13, 2025 (Korea Bizwire) – FreedomPay, a leader in Next Level Commerce™ technologies, today announced a strategic alliance with Mastercard. This collaboration will provide businesses worldwide with a simplified and extended global payment gateway solution, streamlining their ability to connect with acquirers and [...]

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

Klinge Biopharma GmbH (Klinge) holds the exclusive global commercialization rights for FYB203, Formycon’s biosimilar candidate to Eylea®1 Agreement builds on the proven and successful collaboration of commercialization of FYB201, Formycon’s biosimilar to Lucentis®2 (ranibizumab) in Europe The partnership broadens Teva’s biosimilars portfolio, in line with its Pivot to Growth strategy TEL AVIV, Israel, Jan. 13, 2025 [...]

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) and generalized myasthenia gravis (gMG) in the U.S. Partnership supports Teva’s Pivot to Growth strategy and adds to its broad biosimilar portfolio INCHEON, Korea and TEL AVIV, Israel, Jan. 10, 2025 (Korea Bizwire) – Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. [...]

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies TAIPEI, Taiwan, Jan. 8 (Korea Bizwire) — Primo Biotechnology (“Primo”) today announced a strategic partnership with SHINE Technologies, LLC, (“SHINE”) a global leader in nuclear medicine production. The partnership includes a supply and exclusive distribution agreement to introduce Ilumira (n.c.a. lutetium-177, Lu-177), [...]

Sony Honda Mobility and HERE Technologies Partnering to Reshape the Future of Connected EVs and Software-defined Vehicles

Sony Honda Mobility and HERE Technologies Partnering to Reshape the Future of Connected EVs and Software-defined Vehicles

With HERE Navigation SDK, Sony Honda Mobility plans to power AFEELA’s digital cockpit with a connected, software-defined, in-car guidance experience that serves as an extension of the driver’s daily life. The partnership delivers HERE’s unified mapping architecture to the AFEELA which enables state of the art visualization and augmented reality capabilities. Las Vegas, Jan. 7 (Korea Bizwire) – HERE Technologies, the leading location data and technology platform, today [...]

Ambiq and ThinkAR Disrupt the AR Glasses Industry with the AiLens

Ambiq and ThinkAR Disrupt the AR Glasses Industry with the AiLens

AUSTIN, Texas, Jan. 07, 2025 (Korea Bizwire) – Ambiq®, a leading developer of ultra-low-power semiconductors and solutions enabling Edge AI, has partnered with ThinkAR, a pioneer in augmented reality (AR) and AI technology, to unveil AiLens, the most lightweight smart glasses designed for everyday wear. Weighing just 37 grams, AiLens redefines lightweight smart glasses with an extraordinary 10+ [...]

LambdaTest partners with TO THE NEW to Accelerate Digital Innovation for Businesses Globally

LambdaTest partners with TO THE NEW to Accelerate Digital Innovation for Businesses Globally

LambdaTest Partners with TO THE NEW to Enhance Business Efficiency with Cutting-Edge Cloud and Digital Engineering Solutions Noida/San Francisco, Dec. 19, 2024 (Korea Bizwire) – LambdaTest, a leading cloud-based unified testing platform has announced a strategic partnership with TO THE NEW, a leading digital technology services company. This collaboration aims to empower businesses globally by combining [...]

Mavenir and Spry Fox Networks (SFN) Announce Strategic Partnership to Accelerate API Monetization in the Telecom Industry

Mavenir and Spry Fox Networks (SFN) Announce Strategic Partnership to Accelerate API Monetization in the Telecom Industry

Communication Service Providers (CSPs) can now rapidly deploy a comprehensive GSMA Open Gateway based platform by leveraging a pre-integrated solution that combines Mavenir’s Digital Enablement (MDE) Portfolio and Spry Fox Networks’ QP Cloud MONET. This powerful combination provides CSPs with end-to-end API monetization capabilities, enabling them to quickly capitalize on new revenue streams. RICHARDSON, Texas, Dec. [...]

Copenhagen Infrastructure Partners and Google sign power purchase agreement in The Netherlands

Copenhagen Infrastructure Partners and Google sign power purchase agreement in The Netherlands

Google has signed a 250MW power purchase agreement with Copenhagen Infrastructure Partners to purchase renewable energy generated by the Zeevonk project for 15 years. COPENHAGEN, Denmark, Dec. 18, 2024 (Korea Bizwire) – Copenhagen Infrastructure Partners (CIP), through its Energy Transition Fund I, announced today that it has entered a power purchase agreement with Google in [...]

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Teva hosting investor call today at 8:00 a.m. ET (U.S.) Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the most common forms of inflammatory bowel disease (IBD) Primary endpoint results in UC and CD for high dose represent the highest achieved with any TL1A monoclonal antibody Sanofi and Teva plan to initiate [...]